AdaptHealth (AHCO) Cash & Equivalents (2017 - 2026)

AdaptHealth has reported Cash & Equivalents for 10 years, with the latest figure at $48.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 10.6% year-over-year to $48.0 million; the trailing twelve-month figure through Mar 2026 stood at $48.0 million (down 10.6% YoY), and the FY2025 full-year result was $106.1 million, down 3.29% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $48.0 million, down from $106.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $119.4 million in Q1 2022, with the low at $45.1 million in Q2 2023.
• Average Cash & Equivalents over 5 years is $81.8 million, with a median of $79.6 million recorded in 2024.
• Year-over-year, Cash & Equivalents tumbled 69.08% in 2022 and surged 78.44% in 2024.
• Tracing AHCO's Cash & Equivalents over 5 years: stood at $46.3 million in 2022, then surged by 66.69% to $77.1 million in 2023, then soared by 42.28% to $109.7 million in 2024, then declined by 3.29% to $106.1 million in 2025, then sank by 54.81% to $48.0 million in 2026.
• The last three Cash & Equivalents figures came in at $48.0 million (Q1 2026), $106.1 million (Q4 2025), and $80.4 million (Q3 2025), per Business Quant data.

Peer Comparison